ORBIMED ADVISORS LLC Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for September 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 5,555,186 | 0 | 5,555,186 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 413,234 | 0 | 0 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 619,850 | 0 | 0 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,945,458 | 0 | 0 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,418,186 | 0 | 0 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,196,494 | 0 | 0 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,294,743 | 0 | 0 | |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 8,332,779 | 0 | 9,250,191 | 917.4 K to 9.3 M (+908.29 %) |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 710,500 | 13,499,500 | 917,412 | 206.9 K to 917.4 K (+343.38 %) |
| Sep 29 2020 | PRLD | Prelude Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 19.00 | 526,300 | 9,999,700 | 526,300 | 0 to 526.3 K |
| Sep 29 2020 | GRAY | GRAYBUG VISION, IN ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 846,574 | 0 | 0 | |
| Sep 29 2020 | GRAY | GRAYBUG VISION, IN ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 2,754,273 | 0 | 0 | |
| Sep 29 2020 | GRAY | GRAYBUG VISION, IN ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,600,847 | 0 | 4,163,347 | 562.5 K to 4.2 M (+640.15 %) |
| Sep 29 2020 | GRAY | GRAYBUG VISION, IN ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 16.00 | 562,500 | 9,000,000 | 562,500 | 0 to 562.5 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 114,039 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 380,133 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 518,191 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,076,891 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,025,076 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 114,039 | 0 | 114,039 | 0 to 114 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 380,133 | 0 | 6,475,291 | 6.1 M to 6.5 M (+6.24 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 518,191 | 0 | 6,095,158 | 5.6 M to 6.1 M (+9.29 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,076,891 | 0 | 5,576,967 | 4.5 M to 5.6 M (+23.93 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 4,025,076 | 0 | 4,500,076 | 475 K to 4.5 M (+847.38 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 23 2020 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Sell | S | 28.00 | 137,500 | 3,850,000 | 1,864,721 | 2 M to 1.9 M (-6.87 %) |
| Sep 23 2020 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Sell | S | 28.00 | 137,500 | 3,850,000 | 1,864,721 | 2 M to 1.9 M (-6.87 %) |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 16.11 | 30,000 | 483,300 | 30,000 | |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 292,607 | 0 | 292,607 | 0 to 292.6 K |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 902,885 | 0 | 902,855 | -30 to 902.9 K (-3,009,616.67 %) |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Director | Grant | A | 0.00 | 4,822,960 | 0 | 4,822,960 | 0 to 4.8 M |